SÜSS MicroTec (SMHN) Q3 2025 TU earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2025 TU earnings summary
6 Nov, 2025Preliminary Q3 2025 Results and Financial Performance
Q3 order intake declined to €70.0 million, down 16.7% year-over-year, reflecting muted demand momentum.
Q3 sales were €118.0 million, up 15.1% year-over-year but lower than Q1 and Q2.
Gross profit margin for Q3 was 33.1%, a 5.9 percentage point year-over-year drop and below consensus.
EBIT margin for Q3 was 10.5%, underperforming consensus and down 6.4 percentage points year-over-year.
For the first nine months, order intake was €236.8 million, sales €384.4 million, gross profit margin 35.9%, and EBIT margin 14.1%.
Margin Pressure and Contributing Factors
Margin pressure was driven by double rent and relocation costs in Taiwan, lower fixed cost coverage, and an unfavorable product/customer mix.
Expenses from establishing a new production site in Zhubei, Taiwan, contributed to higher costs.
Lower business volume and unforeseen expenses further impacted margins.
Push-outs of high-margin projects and pull-ins of lower-margin ones affected profitability.
No direct competition from ASML’s new advanced packaging tool; different application focus.
Updated Guidance and Management Actions
Full-year 2025 sales guidance remains at €470–510 million.
Gross profit margin guidance for 2025 is lowered to 35–37%, and EBIT margin to 11–13%.
No major margin recovery is expected in Q4; similar product mix and lower sales volume anticipated.
Management is implementing strict cost management and considering structural cost base reductions.
Q4 order intake is expected to improve, potentially exceeding €100 million.
Latest events from SÜSS MicroTec
- Sales up 45.6%, EBIT margin at 15.6%, and guidance raised on strong order momentum.SMHN
Q2 20242 Feb 2026 - Record sales and margins in 2024 set a strong outlook for 2025 despite one-off costs.SMHN
Q4 202423 Dec 2025 - Record sales and EBIT growth offset by lower order intake and margin pressure, prompting guidance cuts.SMHN
Q2 202523 Nov 2025 - Sales targeted at €750–900 million and 43–45% margin by 2030, led by innovation and services.SMHN
CMD 202521 Nov 2025 - Q1 2025 sales up 31.8%, profit surged, but order intake fell amid rising macro risks.SMHN
Q1 202521 Nov 2025 - Margin pressure and lower net income prompt guidance cut, but Q4 order rebound expected.SMHN
Q3 202513 Nov 2025 - Record Q3 results and strong order book drive upgraded outlook and capacity expansion.SMHN
Q3 202413 Jun 2025